Cargando…

Correction: Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258483/ https://www.ncbi.nlm.nih.gov/pubmed/35790335 http://dx.doi.org/10.1136/bmjopen-2021-059223corr1

Ejemplares similares

Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature
por: Lane, Samantha, et al.
Publicado: (2022)

COVID-19 mRNA vaccination and myocarditis or pericarditis
por: Husby, Anders, et al.
Publicado: (2022)

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination
por: Lane, Samantha, et al.
Publicado: (2022)

PRAC updates risk of myocarditis and pericarditis with mRNA vaccines
Publicado: (2021)

Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination
por: Weintraub, Eric S., et al.
Publicado: (2022)

A Pharmacoepidemiological Study of Myocarditis and Pericarditis Following the First Dose of mRNA COVID-19 Vaccine in Europe
por: Tome, Joana, et al.
Publicado: (2023)

COVID-19-Induced Myocarditis and mRNA Vaccine-Related Pericarditis: A Case Report
por: Voltarelli, Clara L, et al.
Publicado: (2022)

Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases
por: Wong, Hui-Lee, et al.
Publicado: (2022)

Tozinameran: Myocarditis and pericarditis: case report
Publicado: (2022)

Low rate of myocarditis/pericarditis after COVID-19 mRNA vaccines
Publicado: (2022)

Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events
por: Kobayashi, Hidetaka, et al.
Publicado: (2022)

mRNA COVID-19 Vaccine Related Myocarditis and Pericarditis in the Australian Capital Territory
por: O'Driscoll, R., et al.
Publicado: (2022)

Correction: Mahasing et al. Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand. Vaccines 2023, 11, 749
por: Mahasing, Chayanit, et al.
Publicado: (2023)

Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers
por: Luk, Adriana, et al.
Publicado: (2021)

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations
por: Alami, Abdallah, et al.
Publicado: (2022)

mRNA-1273: Myocarditis: case report
Publicado: (2021)

Elasomeran/tozinameran: Myocarditis, perimyocarditis and pericarditis: 16 case reports
Publicado: (2022)

Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective
por: Alami, Abdallah, et al.
Publicado: (2023)

COVID-19, Myocarditis and Pericarditis
por: Fairweather, DeLisa, et al.
Publicado: (2023)

Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre
por: Istampoulouoglou, Ioanna, et al.
Publicado: (2021)

Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
por: Das, Bibhuti B., et al.
Publicado: (2021)

Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
por: Goddard, Kristin, et al.
Publicado: (2022)

Acute Myocarditis and Pericarditis After mRNA COVID-19 Vaccinations—A Single-Centre Retrospective Analysis
por: Wassif, Marina, et al.
Publicado: (2023)

Response to case report on myocarditis and pericarditis after COVID‐19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Constrictive pericarditis caused by viral myocarditis in children: a brief report
por: Lei, Haiyan, et al.
Publicado: (2022)

Myocarditis and Pericarditis in Patients with COVID-19
por: Shah, Jassim Zaheen, et al.
Publicado: (2020)

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
por: Rafaniello, Concetta, et al.
Publicado: (2022)

Myocarditis and pericarditis following mRNA vaccination in autoimmune inflammatory rheumatic disease patients: A single‐center experience
por: Patel, Shreeya, et al.
Publicado: (2022)

Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis
por: Alami, Abdallah, et al.
Publicado: (2023)

Comment on: Acute Myocarditis and Pericarditis After mRNA COVID-19 Vaccinations—A Single-Centre Retrospective Analysis
por: Zafar, Wirda, et al.
Publicado: (2023)

Correction to: Rilonacept (Interleukin‑1 Inhibition) for the Treatment of Pericarditis
por: Wang, Tom Kai Ming, et al.
Publicado: (2022)

Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
por: Salvo, Francesco, et al.
Publicado: (2023)

mRNA-1273/tozinameran: Myocarditis: 6 case reports
Publicado: (2021)

mRNA-1273/tozinameran: Myocarditis: 3 case reports
Publicado: (2021)

mRNA-1273/tozinameran: Myocarditis: 4 case reports
Publicado: (2022)

Canadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination
Publicado: (2022)

Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines
por: Naveed, Zaeema, et al.
Publicado: (2022)

Myocarditis and pericarditis after vaccination for COVID‐19
por: Hudson, Blake, et al.
Publicado: (2021)

Myocarditis, pericarditis with COVID-19 vaccines in the Netherlands
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8h4pqr10q8urn9je9kmfm7pdrt